The saga of Once Upon a Time in Shaolin, the one-of-a-kind Wu-Tang Clan album that Martin “pharma bro” Shkreli bought for ...

Martin Shkreli has been sued in New York by a digital art collective that said it paid $4.75 million for a one-of-a-kind album by the hip-hop group Wu-Tang Clan, only to learn that the convicted ...

A federal judge on Friday banned the controversial former pharmaceutical executive Martin Shkreli from ever working in that industry again and ordered him to return $64.6 million in wrongfully ...

Convicted “Pharma Bro” Martin Shkreli has finally been ousted as boss of the pharmaceutical company he founded, The Post has learned. Activist shareholders booted the group of directors still ...

Martin Shkreli’s Ex-Mentor Testifies About His Bad Behavior Steven Richardson, who as chairman of Retrophin fired him as chief executive, was a witness in Mr. Shkreli’s Brooklyn trial on ...

Martin Shkreli, famous for jacking up the price of a generic drug, is touting a weird deal he says he made with Barron Trump. But his reputation for fraud precedes him.

Martin Shkreli, the former pharmaceutical executive known for raising the price of a lifesaving drug more than 40-fold, has been released from prison, where he had been serving a seven-year term ...

Martin Shkreli, controversial drug CEO, arrested for fraud Already convicted of greed in the court of public opinion, Martin Shrekli now stands accused of fraud in a court of law.

Shkreli's father was also present for the reading of the verdict. Former drug company executive Martin Shkreli exits the U.S. District Court in Brooklyn, New York, July 28, 2017.

Shkreli initially filed a request for compassionate release in March but was denied by the prison warden. He appealed the decision to the U.S. District Court in the Eastern District of New York ...

NEW YORK — A federal judge on Friday sentenced Martin Shkreli, the notorious former hedge fund manager, to seven years in prison for defrauding his investors of $10 million.

Martin Shkreli’s journey from pharma exec to inmate No. 87850-053 » Less than a year later, the U.S. indicted him, accusing Shkreli of running his funds like Ponzi schemes.